New research has found that weight/body mass index (BMI) policies introduced by NHS commissioning groups in England are associated with a decrease in knee replacement surgery and may be contributing to health inequalities.
Some public venues may need better ventilation to prevent the spread of COVID-19 following growing evidence of the potential for 'long distance' airborne transmission of the disease,
UVA Health researchers and their collaborators have developed a better way to predict the risk of chronic obstructive pulmonary disease (COPD), a progressive, potentially deadly form of lung inflammation, for people of non-European ancestry.
School of Medicine scientists have identified a potential way to improve heart function after heart attacks – and it could involve a drug extracted from plants commonly used as folk medicine.
Postpartum depression symptoms increased among U.S. women during the first year of the COVID-19 pandemic, a new UVA Health study reveals.
By turning off a single gene, University of Virginia researchers and their collaborators caused stem cells already becoming heart cells to change course and become future brain cells.
Nanoengineered drugs that stop harmful bacteria and viruses could be on the horizon
Scientists have identified a new role for a protein complex at the center of a human genetic disorder called Bardet-Biedl syndrome, or BBS, for which there is currently no cure.
MIT senior Sherry Nyeo, a student since Fall 2019, has conducted groundbreaking work in multiple labs, served as a mentor to dozens of students, and made a lasting mark on the larger MIT community
For fully vaccinated adults, a booster of any of the FDA-authorized COVID-19 vaccines was found to enhance immunity.
People vaccinated three times or vaccinated after an earlier COVID-19 infection had comparable neutralizing antibody activity to those with a breakthrough case.
A safe and effective drug against a parasitic amoeba could come from a new approach that exploits the parasite’s need for iron
Your immune system’s ability to combat COVID-19, like any infection, largely depends on its ability to replicate the immune cells effective at destroying the SARS-CoV-2 virus that causes the disease.
A new study from the University of Michigan describes one of the first entirely new drug delivery microencapsulation approaches in decades.
Researchers at the University of Washington have developed a new test for COVID-19 that combines the speed of over-the-counter antigen tests with the accuracy of PCR tests that are processed in medical labs and hospitals.
One viral protein could provide information to deter pneumonia causing the body’s exaggerated inflammatory response to respiratory viruses, including the virus that causes COVID-19.
Researchers in the Department of Neurosurgery at Yale School of Medicine have discovered the immune-mediated pathobiological process underlying two common types of acquired hydrocephalus.
Preeclampsia is a dangerous complication during pregnancy that endangers both the mother and fetus, but clinicians still don’t have an effective way of predicting who will develop it.
A new Yale study reveals insights into how Omicron subvariants of the SARS-CoV-2 virus evade destruction by T cells.
One of the most terrifying aspects of cancer is its unpredictability: Some cancerous tumors are cured by treatment, while others shrink with treatment only to return later.